Episode 2: Resection to Report - The PD-L1 Testing Journey

The second episode of the "Dialogues in CDx" podcast series takes a closer look at the PD-L1 testing journey. Using England as example, you’ll learn about the process from start to finish, and topics, such as the importance of turnaround times, reflex testing, optimal oncologist-pathologist collaboration, and more, are discussed.  Joining this discussion are two esteemed guests, providing perspectives from both a pathologist’s and an oncologist’s viewpoint. Dr. Phillipe Taniere is a Consultant Histopathologist and Clinical Service Lead for Molecular Pathology at University Hospitals Birmingham. Dr. Taniere’s department completed 20,000 CDx tests last year and is therefore an ideal candidate for this discussion.  Also joining is Dr. Shobhit Baijal, a Consultant Medical Oncologist at the University Hospitals Birmingham NHS Trust and an Honorary Associate Professor at the University of Birmingham where he specializes in the treatment of thoracic and colorectal malignancies. Dr. Baijal specializes in all forms of cancer therapy and is a UK Chief and Principal Investigator for National and International studies. He is also a steering committee member of the British Thoracic Oncology Group. His vast experience provides invaluable input to the discussion. This podcast series is part of the educational resources supporting the PD-L1 IHC 22C3 pharmDx assay. For access to all episodes plus a wealth of additional PD-L1 education for pathologists, explore Agilent's CDx Digital Education Portal today. D0130686_1.00